{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:25:15Z","timestamp":1794011115976,"version":"4.8.0"},"reference-count":216,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-025-02410-x","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T01:44:59Z","timestamp":1753321499000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":146,"title":["PEGylated PLGA nanoparticles: unlocking advanced strategies for cancer therapy"],"prefix":"10.1186","volume":"24","author":[{"given":"Prashant","family":"Kesharwani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khang Wen","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garima","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrhman","family":"Alsayari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadma","family":"Wahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,24]]},"reference":[{"key":"2410_CR1","doi-asserted-by":"crossref","unstructured":"Veselov VV, Nosyrev AE, Jicsinszky L, Alyautdin RN, Cravotto G. Targeted delivery methods for anticancer drugs. Cancers (Basel). 2022;14.","DOI":"10.3390\/cancers14030622"},{"key":"2410_CR2","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.2147\/IJN.S289443","volume":"16","author":"Z Edis","year":"2021","unstructured":"Edis Z, Wang J, Waqas MK, Ijaz M, Ijaz M. Nanocarriers-Mediated drug delivery systems for anticancer agents: an overview and perspectives. Int J Nanomed. 2021;16:1313\u201330.","journal-title":"Int J Nanomed"},{"key":"2410_CR3","doi-asserted-by":"crossref","unstructured":"Jain A, Jain A, Parajuli P, Mishra V, Ghoshal G, Singh B et al. Recent advances in galactose-engineered nanocarriers for the site-specific delivery of SiRNA and anticancer drugs. Drug Discov Today. 2017.","DOI":"10.1016\/j.drudis.2017.11.003"},{"key":"2410_CR4","doi-asserted-by":"crossref","unstructured":"Dubey SK, Kali M, Hejmady S, Saha RN, Alexander A, Kesharwani P. Recent advances of dendrimers as multifunctional nano-carriers to combat breast cancer. Eur J Pharm Sci [Internet]. 2021 [cited 2021 Jun 13];164:105890. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098721001913","DOI":"10.1016\/j.ejps.2021.105890"},{"key":"2410_CR5","doi-asserted-by":"crossref","unstructured":"Kesharwani P, Mishra V, Jain NK. Validating the anticancer potential of carbon nanotube-based therapeutics through cell line testing. Drug Discov. Today. Elsevier Ltd; 2015. pp. 1049\u201360.","DOI":"10.1016\/j.drudis.2015.05.004"},{"key":"2410_CR6","doi-asserted-by":"crossref","unstructured":"Yang H, Li Q, Chen X, Weng M, Huang Y, Chen Q et al. Targeting SOX13 inhibits assembly of respiratory chain supercomplexes to overcome ferroptosis resistance in gastric cancer. Nat Commun 2024 151 [Internet]. 2024 [cited 2025 Jun 14];15:1\u201321. Available from: https:\/\/www.nature.com\/articles\/s41467-024-48307-z","DOI":"10.1038\/s41467-024-48307-z"},{"key":"2410_CR7","doi-asserted-by":"crossref","unstructured":"Liu Y, Wang Z, Tang Z, Fu Y, Wang L. mirna-383-5p Functions as an Anti-oncogene in Glioma through the Akt\/mTOR Signaling Pathway by Targeting VEGFA. Curr Cancer Drug Targets [Internet]. 2023 [cited 2025 Jul 14];24:463\u201375. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37592783\/","DOI":"10.2174\/1568009623666230817102104"},{"key":"2410_CR8","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jconrel.2020.08.067","volume":"328","author":"SK Jha","year":"2020","unstructured":"Jha SK, Chung JY, Pangeni R, Choi HS, Subedi L, Kweon S, et al. Enhanced antitumor efficacy of bile acid-lipid complex-anchored docetaxel nanoemulsion via oral metronomic scheduling. J Control Release. 2020;328:368\u201394.","journal-title":"J Control Release"},{"key":"2410_CR9","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1080\/10717544.2020.1837293","volume":"27","author":"SK Jha","year":"2020","unstructured":"Jha SK, Han HS, Subedi L, Pangeni R, Chung JY, Kweon S, et al. Enhanced oral bioavailability of an Etoposide multiple nanoemulsion incorporating a deoxycholic acid derivative\u2013lipid complex. Drug Deliv. 2020;27:1501\u201313.","journal-title":"Drug Deliv"},{"issue":"3475","key":"2410_CR10","first-page":"3475","volume":"28","author":"M Imran","year":"2023","unstructured":"Imran M, Insaf A, Hasan N, Sugandhi VV, Shrestha D, Paudel KR, et al. Exploring the remarkable chemotherapeutic potential of polyphenolic antioxidants in battling various forms of Cancer. Mol 2023. 2023;28(3475):28:3475.","journal-title":"Mol 2023"},{"key":"2410_CR11","doi-asserted-by":"crossref","unstructured":"Maharjan R, Subedi L, Pangeni R, Jha SK, Kang SH, Chang KY et al. Metronomic delivery of orally available pemetrexed-incorporated colloidal dispersions for boosting tumor-specific immunity. Drug Deliv [Internet]. 2021 [cited 2024 May 6];28:2313\u201328. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34730056\/","DOI":"10.1080\/10717544.2021.1995077"},{"key":"2410_CR12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.2217\/nnm-2021-0444","volume":"17","author":"SK Jha","year":"2022","unstructured":"Jha SK, Imran M, Paudel KR, Mohammed Y, Hansbro P, Dua K. Treating primary lymphoma of the brain in AIDS patients via multifunctional oral nanoparticulate systems. Nanomed (Lond). 2022;17:425\u20139.","journal-title":"Nanomed (Lond)"},{"key":"2410_CR13","doi-asserted-by":"crossref","unstructured":"Zhang M, Yang C, Yan X, Sung J, Garg P, Merlin D. Highly biocompatible functionalized Layer-by-Layer ginger lipid nano vectors targeting P-selectin for delivery of doxorubicin to treat Colon cancer. Adv Ther. 2019;2.","DOI":"10.1002\/adtp.201900129"},{"key":"2410_CR14","doi-asserted-by":"publisher","first-page":"111156","DOI":"10.1016\/j.eurpolymj.2022.111156","volume":"170","author":"M Fatima","year":"2022","unstructured":"Fatima M, Sheikh A, Hasan N, Sahebkar A, Riadi Y, Kesharwani P. Folic acid conjugated poly(amidoamine) dendrimer as a smart nanocarriers for tracing, imaging, and treating cancers over-expressing folate receptors. Eur Polym J. 2022;170:111156.","journal-title":"Eur Polym J"},{"key":"2410_CR15","doi-asserted-by":"publisher","first-page":"111898","DOI":"10.1016\/j.eurpolymj.2023.111898","volume":"187","author":"TT Dongsar","year":"2023","unstructured":"Dongsar TT, Dongsar TS, Abourehab MAS, Gupta N, Kesharwani P. Emerging application of magnetic nanoparticles for breast cancer therapy. Eur Polym J. 2023;187:111898.","journal-title":"Eur Polym J"},{"key":"2410_CR16","doi-asserted-by":"crossref","unstructured":"Madamsetty VS, Tavakol S, Moghassemi S, Dadashzadeh A, Schneible JD, Fatemi I et al. Chitosan: A versatile bio-platform for breast cancer theranostics. J Control Release [Internet]. 2021 [cited 2021 Dec 23];341:733\u201352. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34906606\/","DOI":"10.1016\/j.jconrel.2021.12.012"},{"key":"2410_CR17","doi-asserted-by":"publisher","unstructured":"Aggarwal R, Sheikh A, Akhtar M, Ghazwani M, Hani U, Sahebkar A et al. Understanding gold nanoparticles and their attributes in ovarian cancer therapy. Mol Cancer 2025 241 [Internet]. 2025 [cited 2025 Apr 6];24:1\u201325. Available from: https:\/\/link.springer.com\/articles\/https:\/\/doi.org\/10.1186\/s12943-025-02280-3","DOI":"10.1186\/s12943-025-02280-3"},{"key":"2410_CR18","doi-asserted-by":"crossref","unstructured":"Panthi VK, Jha SK, Pangeni R, Paudel KR. Formulation and Development of Adapalene Topical Nanohydrogel Using Different Surfactants and Cosurfactants for Antiacne Activity: In Vitro and Ex Vivo Evaluation. J Nanomater. 2022;2022.","DOI":"10.1155\/2022\/6889293"},{"key":"2410_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jconrel.2020.03.012","volume":"322","author":"JU Choi","year":"2020","unstructured":"Choi JU, Maharjan R, Pangeni R, Jha SK, Lee NK, Kweon S, et al. Modulating tumor immunity by metronomic dosing of oxaliplatin incorporated in multiple oral nanoemulsion. J Control Release. 2020;322:13\u201330.","journal-title":"J Control Release"},{"key":"2410_CR20","doi-asserted-by":"publisher","first-page":"6339","DOI":"10.2147\/IJN.S209722","volume":"14","author":"R Pangeni","year":"2019","unstructured":"Pangeni R, Jha SK, Maharjan R, Choi JU, Chang KY, Choi YK, et al. Intestinal transport mechanism and in vivo anticancer efficacy of a solid oral formulation incorporating an ion-pairing complex of pemetrexed with deoxycholic acid derivative. Int J Nanomed. 2019;14:6339\u201356.","journal-title":"Int J Nanomed"},{"key":"2410_CR21","doi-asserted-by":"crossref","unstructured":"Jha SK, Pandey S, Karn A, Panthi VK. Synbiotics in gastroesophageal Cancer. Synbiotics Manag Cancer. 2023;305\u201314.","DOI":"10.1007\/978-981-19-7550-9_15"},{"key":"2410_CR22","doi-asserted-by":"publisher","unstructured":"Gowda BHJ, Ahmed MG, Sahebkar A, Riadi Y, Shukla R, Kesharwani P. Stimuli-Responsive Microneedles as a Transdermal Drug Delivery System: A Demand-Supply Strategy. Biomacromolecules [Internet]. 2022 [cited 2022 Apr 4];acs.biomac.1c01691. Available from: https:\/\/pubs.acs.org\/doi\/pdf\/https:\/\/doi.org\/10.1021\/acs.biomac.1c01691","DOI":"10.1021\/acs.biomac.1c01691"},{"key":"2410_CR23","doi-asserted-by":"crossref","unstructured":"Sheikh A, Md S, Alhakamy NA, Kesharwani P. Recent development of aptamer conjugated chitosan nanoparticles as cancer therapeutics. Int J Pharm [Internet]. 2022 [cited 2022 May 1];620:121751. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517322003064","DOI":"10.1016\/j.ijpharm.2022.121751"},{"key":"2410_CR24","doi-asserted-by":"crossref","unstructured":"Moghaddam SH, Vatankhah A, Oroojalian F, Kesharwani P, Sahebkar A. Liposomes as immunotherapeutic carriers: A game-changer in cancer therapy. J Drug Deliv Sci Technol [Internet]. 2025 [cited 2025 May 1];107:106847. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1773224725002503","DOI":"10.1016\/j.jddst.2025.106847"},{"key":"2410_CR25","doi-asserted-by":"publisher","first-page":"106849","DOI":"10.1016\/j.jddst.2025.106849","volume":"107","author":"J Chandra","year":"2025","unstructured":"Chandra J, Molugulu N, Gupta G, Siddiqua A, Wahab S, Kesharwani P. Biomimetic nanoparticles: A revolutionary approach to breast cancer therapy using cell membrane coatings. J Drug Deliv Sci Technol. 2025;107:106849.","journal-title":"J Drug Deliv Sci Technol"},{"key":"2410_CR26","first-page":"416","volume":"15","author":"Q He","year":"2020","unstructured":"He Q, Chen J, Yan J, Cai S, Xiong H, Liu Y, et al. Tumor microenvironment responsive drug delivery systems. Asian J Pharm Sci. 2020;15:416\u201348.","journal-title":"Asian J Pharm Sci"},{"key":"2410_CR27","doi-asserted-by":"crossref","unstructured":"Jha SK, De Rubis G, Devkota SR, Zhang Y, Adhikari R, Jha LA et al. Cellular senescence in lung cancer: molecular mechanisms and therapeutic interventions. Ageing Res Rev. 2024;102315.","DOI":"10.1016\/j.arr.2024.102315"},{"key":"2410_CR28","doi-asserted-by":"publisher","first-page":"121790","DOI":"10.1016\/j.ijpharm.2022.121790","volume":"621","author":"M Imran","year":"2022","unstructured":"Imran M, Jha LA, Hasan N, Shrestha J, Pangeni R, Parvez N, et al. Nanodecoys - Future of drug delivery by encapsulating nanoparticles in natural cell membranes. Int J Pharm. 2022;621:121790.","journal-title":"Int J Pharm"},{"key":"2410_CR29","first-page":"586","volume":"14","author":"M Imran","year":"2022","unstructured":"Imran M, Jha SK, Hasan N, Insaf A, Shrestha J, Shrestha J, et al. Overcoming Multidrug Resist Antibiot Via Nanodelivery Syst Pharm 2022. 2022;14:14:586.","journal-title":"Overcoming Multidrug Resist Antibiot Via Nanodelivery Syst Pharm 2022"},{"key":"2410_CR30","doi-asserted-by":"publisher","unstructured":"Rehman U, Gupta G, Sahebkar A, Kesharwani P. Ammonia-Induced Cell Death: A Novel Frontier to Enhance Cancer Immunotherapy. Immunology [Internet]. 2025 [cited 2025 Apr 6];0:1\u20135. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/https:\/\/doi.org\/10.1111\/imm.13918","DOI":"10.1111\/imm.13918"},{"key":"2410_CR31","doi-asserted-by":"publisher","first-page":"5259","DOI":"10.7150\/thno.29098","volume":"8","author":"Y Jo","year":"2018","unstructured":"Jo Y, Choi N, Kim K, Koo HJ, Choi J, Kim HN. Chemoresistance of Cancer cells: requirements of tumor Microenvironment-mimicking in vitro models in Anti-Cancer drug development. Theranostics. 2018;8:5259\u201375.","journal-title":"Theranostics"},{"key":"2410_CR32","doi-asserted-by":"crossref","unstructured":"Kesharwani P, Jain K, Jain NK. Dendrimer as nanocarrier for drug delivery. Prog Polym Sci. 2014. pp. 268\u2013307.","DOI":"10.1016\/j.progpolymsci.2013.07.005"},{"key":"2410_CR33","doi-asserted-by":"crossref","unstructured":"Luong D, Kesharwani P, Deshmukh R, Mohd Amin MCI, Gupta U, Greish K et al. PEGylated PAMAM dendrimers: enhancing efficacy and mitigating toxicity for effective anticancer drug and gene delivery. Acta Biomater. 2016;43.","DOI":"10.1016\/j.actbio.2016.07.015"},{"key":"2410_CR34","doi-asserted-by":"crossref","unstructured":"Ioele G, Chieffallo M, Occhiuzzi MA, De Luca M, Garofalo A, Ragno G et al. Anticancer Drugs: Recent Strategies to Improve Stability Profile, Pharmacokinetic and Pharmacodynamic Properties. Mol 2022, Vol 27, Page 5436. 2022;27:5436.","DOI":"10.3390\/molecules27175436"},{"key":"2410_CR35","doi-asserted-by":"crossref","unstructured":"Kesharwani P, Gajbhiye V, Tekade RK, Jain NK. Evaluation of dendrimer safety and efficacy through cell line studies. 2011. pp. 1478\u201397.","DOI":"10.2174\/138945011796818135"},{"key":"2410_CR36","doi-asserted-by":"crossref","unstructured":"Mukherjee S, Mukherjee S, Abourehab MAS, Sahebkar A, Kesharwani P. Exploring dendrimer-based drug delivery systems and their potential applications in cancer immunotherapy. Eur Polym J [Internet]. 2022 [cited 2022 Aug 10];177:111471. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001430572200475X","DOI":"10.1016\/j.eurpolymj.2022.111471"},{"key":"2410_CR37","doi-asserted-by":"crossref","unstructured":"Sheikh A, Md S, Kesharwani P. Aptamer grafted nanoparticle as targeted therapeutic tool for the treatment of breast cancer. Biomed Pharmacother [Internet]. 2022 [cited 2021 Dec 29];146:112530. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221013172","DOI":"10.1016\/j.biopha.2021.112530"},{"key":"2410_CR38","doi-asserted-by":"crossref","unstructured":"Kesharwani P, Tekade RK, Jain NK. Dendrimer generational nomenclature: the need to harmonize. Drug Discov Today. 2015;20.","DOI":"10.1016\/j.drudis.2014.12.015"},{"key":"2410_CR39","doi-asserted-by":"crossref","unstructured":"Sheikh A, Kesharwani P. An insight into aptamer engineered dendrimer for cancer therapy. Eur Polym J [Internet]. 2021 [cited 2021 Sep 14];159:110746. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014305721004808","DOI":"10.1016\/j.eurpolymj.2021.110746"},{"key":"2410_CR40","doi-asserted-by":"crossref","unstructured":"Kaur H, Kesharwani P. Advanced nanomedicine approaches applied for treatment of skin carcinoma. J Control Release [Internet]. 2021 [cited 2021 Aug 23];337:589\u2013611. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365921004028","DOI":"10.1016\/j.jconrel.2021.08.003"},{"key":"2410_CR41","doi-asserted-by":"publisher","unstructured":"Yuan H, Chen Y, Hu Y, Li Y, Zhang H, Zhang S et al. Disulfide bond-driven nanoassembly of lipophilic epirubicin prodrugs for breast cancer therapy. J Pharm Investig [Internet]. 2025 [cited 2025 Jun 12];1\u201314. Available from: https:\/\/link.springer.com\/article\/https:\/\/doi.org\/10.1007\/s40005-025-00731-z","DOI":"10.1007\/s40005-025-00731-z"},{"key":"2410_CR42","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1208\/s12248-015-9814-9","volume":"17","author":"H Wen","year":"2015","unstructured":"Wen H, Jung H, Li X. Drug delivery approaches in addressing clinical Pharmacology-Related issues: opportunities and challenges. AAPS J. 2015;17:1327\u201340.","journal-title":"AAPS J"},{"key":"2410_CR43","doi-asserted-by":"publisher","first-page":"e29528","DOI":"10.4161\/tisb.29528","volume":"2","author":"SK Sriraman","year":"2014","unstructured":"Sriraman SK, Aryasomayajula B, Torchilin VP. Barriers to drug delivery in solid tumors. Tissue Barriers. 2014;2:e29528\u20131.","journal-title":"Tissue Barriers"},{"key":"2410_CR44","doi-asserted-by":"publisher","first-page":"1606596","DOI":"10.1002\/adma.201606596","volume":"29","author":"R Yang","year":"2017","unstructured":"Yang R, Wei T, Goldberg H, Wang W, Cullion K, Kohane DS. Getting drugs across biological barriers. Adv Mater. 2017;29:1606596.","journal-title":"Adv Mater"},{"key":"2410_CR45","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1124\/jpet.119.257113","volume":"370","author":"PM Glassman","year":"2019","unstructured":"Glassman PM, Muzykantov VR. Pharmacokinetic and pharmacodynamic properties of drug delivery systems. J Pharmacol Exp Ther. 2019;370:570\u201380.","journal-title":"J Pharmacol Exp Ther"},{"key":"2410_CR46","doi-asserted-by":"crossref","unstructured":"Sun W, Jang MS, Zhan S, Liu C, Sheng L, Lee JH et al. Tumor-targeting and redox-responsive photo-cross-linked nanogel derived from multifunctional hyaluronic acid-lipoic acid conjugates for enhanced in vivo protein delivery. Int J Biol Macromol [Internet]. 2025 [cited 2025 Jun 19];314:144444. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0141813025049967","DOI":"10.1016\/j.ijbiomac.2025.144444"},{"key":"2410_CR47","doi-asserted-by":"crossref","unstructured":"L\u00f4bo GCNB, Paiva KLR, Silva ALG, Sim\u00f5es MM, B\u00e1o SN, Radicchi MA. Nanocarriers Used in Drug Delivery to Enhance Immune System in Cancer Therapy. Pharm 2021, Vol 13, Page 1167. 2021;13:1167.","DOI":"10.3390\/pharmaceutics13081167"},{"key":"2410_CR48","doi-asserted-by":"crossref","unstructured":"Feng C, Wang Y, Xu J, Zheng Y, Zhou W, Wang Y et al. Precisely Tailoring Molecular Structure of Doxorubicin Prodrugs to Enable Stable Nanoassembly, Rapid Activation, and Potent Antitumor Effect. Pharmaceutics [Internet]. 2024 [cited 2025 Jun 24];16. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39771561\/","DOI":"10.3390\/pharmaceutics16121582"},{"key":"2410_CR49","doi-asserted-by":"crossref","unstructured":"Zhou J, Guo Z, Peng X, Wu B, Meng Q, Lu X et al. Chrysotoxine regulates ferroptosis and the PI3K\/AKT\/mTOR pathway to prevent cervical cancer. J Ethnopharmacol [Internet]. 2025 [cited 2025 Jun 14];338:119126. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0378874124014259?via%3Dihub","DOI":"10.1016\/j.jep.2024.119126"},{"key":"2410_CR50","doi-asserted-by":"crossref","unstructured":"Guo L, Fu Z, Li H, Wei R, Guo J, Wang H et al. Smart hydrogel: A new platform for cancer therapy. Adv Colloid Interface Sci [Internet]. 2025 [cited 2025 Jul 8];340:103470. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0001868625000818","DOI":"10.1016\/j.cis.2025.103470"},{"key":"2410_CR51","unstructured":"Mansuri S, Kesharwani P, Tekade RK, Jain NK. Lyophilized mucoadhesive-dendrimer enclosed matrix tablet for extended oral delivery of albendazole. Eur J Pharm Biopharm [Internet]. 2015 [cited 2015 Nov 29]; Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26563727"},{"key":"2410_CR52","doi-asserted-by":"crossref","unstructured":"Paroha S, Verma J, Dubey RD, Dewangan RP, Molugulu N, Bapat RA et al. Recent advances and prospects in gemcitabine drug delivery systems. Int. J. Pharm. Elsevier B.V.; 2020. p. 120043.","DOI":"10.1016\/j.ijpharm.2020.120043"},{"key":"2410_CR53","doi-asserted-by":"crossref","unstructured":"Singh S, Numan A, Maddiboyina B, Arora S, Riadi Y, Md S, et al. The emerging role of immune checkpoint inhibitors in the treatment of triple-negative breast cancer. Drug Discov. Today. Elsevier Ltd; 2021.","DOI":"10.1016\/j.drudis.2021.03.011"},{"key":"2410_CR54","doi-asserted-by":"crossref","unstructured":"Choudhury H, Zakaria NFB, Tilang PAB, Tzeyung AS, Pandey M, Chatterjee B et al. Formulation development and evaluation of rotigotine mucoadhesive nanoemulsion for intranasal delivery. J Drug Deliv Sci Technol. 2019;54.","DOI":"10.1016\/j.jddst.2019.101301"},{"key":"2410_CR55","doi-asserted-by":"crossref","unstructured":"Tekade RK, Tekade M, Kesharwani P, D\u2019Emanuele A. RNAi-combined nano-chemotherapeutics to tackle resistant tumors. Drug Discov Today. 2016;21.","DOI":"10.1016\/j.drudis.2016.06.029"},{"key":"2410_CR56","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.procbio.2021.11.017","volume":"112","author":"SK Dubey","year":"2022","unstructured":"Dubey SK, Parab S, Alexander A, Agrawal M, Achalla VPK, Pal UN, et al. Cold atmospheric plasma therapy in wound healing. Process Biochem. 2022;112:112\u201323.","journal-title":"Process Biochem"},{"key":"2410_CR57","doi-asserted-by":"crossref","unstructured":"Hasan N, Imran M, Kesharwani P, Khanna K, Karwasra R, Sharma N et al. Intranasal delivery of Naloxone-loaded solid lipid nanoparticles as a promising simple and non-invasive approach for the management of opioid overdose. Int J Pharm [Internet]. 2021 [cited 2021 Apr 8];599. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33662465\/","DOI":"10.1016\/j.ijpharm.2021.120428"},{"key":"2410_CR58","doi-asserted-by":"crossref","unstructured":"Chadar R, Afzal O, Alqahtani SM, Kesharwani P. Carbon nanotubes as an emerging nanocarrier for the delivery of doxorubicin for improved chemotherapy. Colloids Surfaces B Biointerfaces [Internet]. 2021 [cited 2021 Aug 23];208:112044. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776521004884","DOI":"10.1016\/j.colsurfb.2021.112044"},{"key":"2410_CR59","doi-asserted-by":"crossref","unstructured":"Chadar R, Afsana, Kesharwani P. Nanotechnology-based SiRNA delivery strategies for treatment of triple negative breast cancer. Int J Pharm. 2021;605.","DOI":"10.1016\/j.ijpharm.2021.120835"},{"key":"2410_CR60","doi-asserted-by":"crossref","unstructured":"Wang Y, Xu Y, Song J, Liu X, Liu S, Yang N et al. Tumor Cell-Targeting and Tumor Microenvironment\u2013Responsive Nanoplatforms for the Multimodal Imaging-Guided Photodynamic\/Photothermal\/Chemodynamic Treatment of Cervical Cancer. Int J Nanomedicine [Internet]. 2024 [cited 2025 Jun 12];19:5837\u201358. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/38887692\/","DOI":"10.2147\/IJN.S466042"},{"key":"2410_CR61","doi-asserted-by":"crossref","unstructured":"Alsaab HO, Alharbi FD, Alhibs AS, Alanazi NB, Alshehri BY, Saleh MA et al. PLGA-Based Nanomedicine: History of Advancement and Development in Clinical Applications of Multiple Diseases. Pharmaceutics [Internet]. 2022 [cited 2023 Jun 15];14. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36559223\/","DOI":"10.3390\/pharmaceutics14122728"},{"key":"2410_CR62","doi-asserted-by":"crossref","unstructured":"Guo X, Zuo X, Zhou Z, Gu Y, Zheng H, Wang X et al. PLGA-Based Micro\/Nanoparticles: An Overview of Their Applications in Respiratory Diseases. Int J Mol Sci. 2023, Vol 24, Page 4333. 2023;24:4333.","DOI":"10.3390\/ijms24054333"},{"key":"2410_CR63","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2013006475","volume":"30","author":"DJ Hines","year":"2013","unstructured":"Hines DJ, Kaplan DL. Poly(lactic-co-glycolic) acid-controlled-release systems: experimental and modeling insights. Crit Rev Ther Drug Carrier Syst. 2013;30:257\u201376.","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"2410_CR64","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","volume":"99","author":"JS Suk","year":"2016","unstructured":"Suk JS, Xu Q, Kim N, Hanes J, Ensign LM. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev. 2016;99:28\u201351.","journal-title":"Adv Drug Deliv Rev"},{"key":"2410_CR65","doi-asserted-by":"crossref","unstructured":"Fam SY, Chee CF, Yong CY, Ho KL, Mariatulqabtiah AR, Tan WS. Stealth Coating of Nanoparticles in Drug-Delivery Systems. Nanomater 2020, Vol 10, Page 787. 2020;10:787.","DOI":"10.3390\/nano10040787"},{"key":"2410_CR66","doi-asserted-by":"publisher","unstructured":"Bajracharya R, Song JG, Patil BR, Lee SH, Noh HM, Kim DH et al. Functional ligands for improving anticancer drug therapy: current status and applications to drug delivery systems. Drug Deliv [Internet]. 2022 [cited 2024 Apr 6];29:1959\u201370. Available from: https:\/\/www.tandfonline.com\/doi\/abs\/https:\/\/doi.org\/10.1080\/10717544.2022.2089296","DOI":"10.1080\/10717544.2022.2089296"},{"key":"2410_CR67","doi-asserted-by":"crossref","unstructured":"Ghitman J, Biru EI, Stan R, Iovu H. Review of hybrid PLGA nanoparticles: future of smart drug delivery and theranostics medicine. Mater Des. 2020.","DOI":"10.1016\/j.matdes.2020.108805"},{"key":"2410_CR68","doi-asserted-by":"crossref","unstructured":"Zhang D, Liu L, Wang J, Zhang H, Zhang Z, Xing G et al. Drug-loaded PEG-PLGA nanoparticles for cancer treatment. Front Pharmacol. 2022;13.","DOI":"10.3389\/fphar.2022.990505"},{"key":"2410_CR69","doi-asserted-by":"crossref","unstructured":"Shen X, Li T, Xie X, Feng Y, Chen Z, Yang H et al. PLGA-Based drug delivery systems for remotely triggered Cancer therapeutic and diagnostic applications. Front Bioeng Biotechnol. 2020;8.","DOI":"10.3389\/fbioe.2020.00381"},{"key":"2410_CR70","doi-asserted-by":"publisher","first-page":"102144","DOI":"10.1016\/j.jddst.2020.102144","volume":"61","author":"N Cheraga","year":"2021","unstructured":"Cheraga N, Sun NC, Huang XX, Ye Z, Xiao QR, Huang NP. Optimized rapamycin-loaded pegylated PLGA nanoparticles: preparation, characterization and pharmacokinetics study. J Drug Deliv Sci Technol. 2021;61:102144.","journal-title":"J Drug Deliv Sci Technol"},{"key":"2410_CR71","doi-asserted-by":"crossref","unstructured":"Cheng J, Teply BA, Sherifi I, Sung J, Luther G, Gu FX et al. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials [Internet]. 2007 [cited 2014 Jul 16];28:869\u201376. Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=2925222%26tool=pmcentrez%26rendertype=abstract","DOI":"10.1016\/j.biomaterials.2006.09.047"},{"key":"2410_CR72","doi-asserted-by":"crossref","unstructured":"Rocha CV, Gon\u00e7alves V, da Silva MC, Ba\u00f1obre-L\u00f3pez M, Gallo J. PLGA-Based Composites for Various Biomedical Applications. Int J Mol Sci 2022, Vol 23, Page. 2034. 2022;23:2034.","DOI":"10.3390\/ijms23042034"},{"key":"2410_CR73","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.apsusc.2015.04.071","volume":"347","author":"S Spek","year":"2015","unstructured":"Spek S, Haeuser M, Schaefer MM, Langer K. Characterisation of pegylated PLGA nanoparticles comparing the nanoparticle bulk to the particle surface using uv\/vis spectroscopy, SEC, 1H NMR spectroscopy, and X-ray photoelectron spectroscopy. Appl Surf Sci. 2015;347:378\u201385.","journal-title":"Appl Surf Sci"},{"key":"2410_CR74","doi-asserted-by":"crossref","unstructured":"Yesenia K, Hern\u00b4hern\u00e1ndez-Giottonini H, Rodr\u00edguezrodr\u00edguez-C \u00b4 Ordova RJ, Gut\u00ed, Errez-Valenzuela CA, Pe\u00f1u\u00f1uri O, Pe\u00f1u P et al. PLGA nanoparticle preparations by emulsification and nanoprecipitation techniques: effects of formulation parameters. RSC Adv. 2020;10:4218\u201331.","DOI":"10.1039\/C9RA10857B"},{"key":"2410_CR75","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1039\/D1MA00600B","volume":"3","author":"M Chatterjee","year":"2022","unstructured":"Chatterjee M, Chanda N. Formulation of PLGA nano-carriers: specialized modification for cancer therapeutic applications. Mater Adv. 2022;3:837\u201358.","journal-title":"Mater Adv"},{"key":"2410_CR76","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s40005-019-00441-3","volume":"49","author":"C Arpagaus","year":"2019","unstructured":"Arpagaus C. PLA\/PLGA nanoparticles prepared by nano spray drying. J Pharm Investig. 2019;49:405\u201326.","journal-title":"J Pharm Investig"},{"key":"2410_CR77","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3389\/fbioe.2020.00048","volume":"8","author":"D Essa","year":"2020","unstructured":"Essa D, Kondiah PPD, Choonara YE, Pillay V. The design of Poly(lactide-co-glycolide) nanocarriers for medical applications. Front Bioeng Biotechnol. 2020;8:48.","journal-title":"Front Bioeng Biotechnol"},{"key":"2410_CR78","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3390\/pharmaceutics12111118","volume":"12","author":"G Gangapurwala","year":"2020","unstructured":"Gangapurwala G, Vollrath A, De San Luis A, Schubert US. PLA\/PLGA-Based drug delivery systems produced with supercritical CO2\u2014A green future for particle formulation?? Pharmaceutics. 2020;12:1118.","journal-title":"Pharmaceutics"},{"key":"2410_CR79","doi-asserted-by":"publisher","first-page":"122368","DOI":"10.1016\/j.ijpharm.2022.122368","volume":"629","author":"E Chiesa","year":"2022","unstructured":"Chiesa E, Bellotti M, Caimi A, Conti B, Dorati R, Conti M, et al. Development and optimization of microfluidic assisted manufacturing process to produce PLGA nanoparticles. Int J Pharm. 2022;629:122368.","journal-title":"Int J Pharm"},{"key":"2410_CR80","doi-asserted-by":"publisher","first-page":"e0206109","DOI":"10.1371\/journal.pone.0206109","volume":"13","author":"V Venugopal","year":"2018","unstructured":"Venugopal V, Krishnan S, Palanimuthu VR, Sankarankutty S, Kalaimani JK, Karupiah S, et al. Anti-EGFR anchored Paclitaxel loaded PLGA nanoparticles for the treatment of triple negative breast cancer. In-vitro and in-vivo anticancer activities. PLoS ONE. 2018;13:e0206109.","journal-title":"PLoS ONE"},{"key":"2410_CR81","doi-asserted-by":"crossref","unstructured":"Nair M, Johal RK, Hamaia SW, Best SM, Cameron RE. Tunable bioactivity and mechanics of collagen-based tissue engineering constructs: A comparison of EDC-NHS, Genipin and TG2 crosslinkers. Biomaterials. 2020;254.","DOI":"10.1016\/j.biomaterials.2020.120109"},{"key":"2410_CR82","doi-asserted-by":"publisher","first-page":"386753","DOI":"10.3389\/fchem.2018.00237","volume":"6","author":"PM Carvalho","year":"2018","unstructured":"Carvalho PM, Fel\u00edcio MR, Santos NC, Gon\u00e7alves S, Domingues MM. Application of light scattering techniques to nanoparticle characterization and development. Front Chem. 2018;6:386753.","journal-title":"Front Chem"},{"key":"2410_CR83","first-page":"100066","volume":"10","author":"D Saha","year":"2021","unstructured":"Saha D, Kumar S, Ray D, Mata J, Aswal VK. Structure and stability of biodegradable polymer nanoparticles in electrolyte solution. Mater Lett X. 2021;10:100066.","journal-title":"Mater Lett X"},{"key":"2410_CR84","doi-asserted-by":"publisher","first-page":"103043","DOI":"10.1016\/j.amsu.2021.103043","volume":"72","author":"DV Peristeri","year":"2021","unstructured":"Peristeri DV, Tepelenis K, Karampa A, Kapodistrias N, Goussia AC, Pappas-Gogos G, et al. Metronomic chemotherapy with cyclophosphamide for the treatment of advanced hepatocellular cancer: A case report. Ann Med Surg. 2021;72:103043.","journal-title":"Ann Med Surg"},{"key":"2410_CR85","doi-asserted-by":"crossref","unstructured":"Ali MS, Jha SK, Gupta G, Alsayari A, Wahab S, Kesharwani P. Advancements in 5-fluorouracil-Loaded liposomal nanosystems: A comprehensive review on recent innovations in nanomedicine for cancer therapy. J Drug Deliv Sci Technol [Internet]. 2024 [cited 2024 May 6];96:105730. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S177322472400399X","DOI":"10.1016\/j.jddst.2024.105730"},{"key":"2410_CR86","first-page":"2818","volume":"10","author":"NW Su","year":"2021","unstructured":"Su NW, Chen YJ. Metronomic therapy in oral squamous cell carcinoma. J Clin Med 2021. 2021;10:10:2818.","journal-title":"J Clin Med 2021"},{"key":"2410_CR87","doi-asserted-by":"publisher","first-page":"216900","DOI":"10.1016\/j.canlet.2024.216900","volume":"591","author":"M Banchi","year":"2024","unstructured":"Banchi M, Cox MC, Bocci G. Metronomic chemotherapy in hematology: lessons from preclinical and clinical studies to build a solid rationale for future schedules. Cancer Lett. 2024;591:216900.","journal-title":"Cancer Lett"},{"key":"2410_CR88","doi-asserted-by":"crossref","unstructured":"Teleanu RI, Chircov C, Grumezescu AM, Teleanu DM. Tumor angiogenesis and Anti-Angiogenic strategies for Cancer treatment. J Clin Med. 2019;9.","DOI":"10.3390\/jcm9010084"},{"key":"2410_CR89","doi-asserted-by":"crossref","unstructured":"Jan N, Sofi S, Qayoom H, Shabir A, Haq BU, Macha MA et al. Metronomic chemotherapy and drug repurposing: A paradigm shift in oncology. Heliyon [Internet]. 2024 [cited 2024 Jul 4];10. Available from: http:\/\/www.cell.com\/article\/S2405844024007011\/fulltext","DOI":"10.1016\/j.heliyon.2024.e24670"},{"key":"2410_CR90","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.3390\/ijms18102134","volume":"18","author":"I Kareva","year":"2017","unstructured":"Kareva I. A combination of immune checkpoint Inhibition with metronomic chemotherapy as a way of targeting Therapy-Resistant Cancer cells. Int J Mol Sci 2017. 2017;18:18:2134.","journal-title":"Int J Mol Sci 2017"},{"key":"2410_CR91","doi-asserted-by":"crossref","unstructured":"Kumar NAN, Dikhit PS, Jose A, Mehta V, Pai A, Kudva A et al. Oral metronomic chemotherapy in advanced and metastatic oral squamous cell carcinoma: A need of the hour. J Maxillofac Oral Surg. 2023;1\u20138.","DOI":"10.1007\/s12663-023-01963-y"},{"key":"2410_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12964-022-00838-y","volume":"20","author":"MJ Ansari","year":"2022","unstructured":"Ansari MJ, Bokov D, Markov A, Jalil AT, Shalaby MN, Suksatan W, et al. Cancer combination therapies by angiogenesis inhibitors; a comprehensive review. Cell Commun Signal. 2022;20:1\u201323.","journal-title":"Cell Commun Signal"},{"key":"2410_CR93","doi-asserted-by":"publisher","first-page":"7491","DOI":"10.2147\/IJN.S257758","volume":"15","author":"Q Liang","year":"2020","unstructured":"Liang Q, Xiang H, Li X, Luo C, Ma X, Zhao W, et al. Development of Rifapentine-Loaded PLGA-Based nanoparticles: in vitro characterisation and in vivo study in mice. Int J Nanomed. 2020;15:7491\u2013507.","journal-title":"Int J Nanomed"},{"key":"2410_CR94","doi-asserted-by":"crossref","unstructured":"Sun L, Liu H, Ye Y, Lei Y, Islam R, Tan S et al. Smart nanoparticles for cancer therapy. Signal Transduct Target Ther 2023 81. 2023;8:1\u201328.","DOI":"10.1038\/s41392-023-01642-x"},{"key":"2410_CR95","doi-asserted-by":"crossref","unstructured":"Alvi M, Yaqoob A, Rehman K, Shoaib SM, Akash MSH. PLGA-based nanoparticles for the treatment of cancer: current strategies and perspectives. AAPS Open 2022 81. 2022;8:1\u201317.","DOI":"10.1186\/s41120-022-00060-7"},{"key":"2410_CR96","doi-asserted-by":"crossref","unstructured":"Jo\u00e3o M, Gouveia C, Horvath D, Basler M. PLGA Particles in Immunotherapy. Pharm 2023, Vol 15, Page 615. 2023;15:615.","DOI":"10.3390\/pharmaceutics15020615"},{"key":"2410_CR97","doi-asserted-by":"crossref","unstructured":"Jha SK, Imran M, Jha LA, Hasan N, Panthi VK, Paudel KR et al. A Comprehensive review on Pharmacokinetic Studies of Vaccines: Impact of delivery route, carrier-and its modulation on immune response. Environ Res [Internet]. 2023 [cited 2024 May 6];236. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37543130\/","DOI":"10.1016\/j.envres.2023.116823"},{"key":"2410_CR98","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.2217\/nnm-2017-0254","volume":"12","author":"CB Chesson","year":"2017","unstructured":"Chesson CB, Zloza A, Nanoparticles. Augmenting tumor antigen presentation for vaccine and immunotherapy treatments of cancer. Nanomedicine. 2017;12:2693\u2013706.","journal-title":"Nanomedicine"},{"key":"2410_CR99","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.2147\/IJN.S450205","volume":"19","author":"H Yuan","year":"2024","unstructured":"Yuan H, Gui H, Chen S, Zhu L, Wang C, Jing Q, et al. Regulating Tumor-Associated macrophage polarization by Cyclodextrin-Modified PLGA nanoparticles loaded with R848 for treating Colon cancer. Int J Nanomed. 2024;19:3589\u2013605.","journal-title":"Int J Nanomed"},{"key":"2410_CR100","doi-asserted-by":"crossref","unstructured":"Khatun S, Putta CL, Hak A, Rengan AK. Immunomodulatory nanosystems: an emerging strategy to combat viral infections. Biomater Biosyst. 2023;9.","DOI":"10.1016\/j.bbiosy.2023.100073"},{"key":"2410_CR101","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.bmt.2023.09.001","volume":"5","author":"K Elumalai","year":"2024","unstructured":"Elumalai K, Srinivasan S, Shanmugam A. Review of the efficacy of nanoparticle-based drug delivery systems for cancer treatment. Biomed Technol. 2024;5:109\u201322.","journal-title":"Biomed Technol"},{"key":"2410_CR102","doi-asserted-by":"crossref","unstructured":"El-Hammadi MM, Arias JL. Recent Advances in the Surface Functionalization of PLGA-Based Nanomedicines. Nanomater 2022, Vol 12, Page 354. 2022;12:354.","DOI":"10.3390\/nano12030354"},{"key":"2410_CR103","doi-asserted-by":"crossref","unstructured":"Lee CK, Atibalentja DF, Yao LE, Park J, Kuruvilla S, Felsher DW, Anti. -PD-L1 F(ab) Conjugated PEG-PLGA Nanoparticle Enhances Immune Checkpoint Therapy. Nanotheranostics [Internet]. 2021 [cited 2025 Jun 6];6:243\u201355. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35145835\/","DOI":"10.7150\/ntno.65544"},{"key":"2410_CR104","first-page":"1","volume":"7","author":"Q Chen","year":"2016","unstructured":"Chen Q, Xu L, Liang C, Wang C, Peng R, Liu Z. Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint Blockade for effective cancer immunotherapy. Nat Commun 2016 71. 2016;7:1\u201313.","journal-title":"Nat Commun 2016 71"},{"key":"2410_CR105","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.nano.2019.02.001","volume":"17","author":"Z Li","year":"2019","unstructured":"Li Z, Yin Q, Chen B, Wang Z, Yan Y, Qi T, et al. Ultra-pH-sensitive indocyanine green-conjugated nanoprobes for fluorescence imaging-guided photothermal cancer therapy. Nanomedicine. 2019;17:287\u201396.","journal-title":"Nanomedicine"},{"key":"2410_CR106","doi-asserted-by":"publisher","first-page":"6209","DOI":"10.1039\/C9CC02567G","volume":"55","author":"L Zhu","year":"2019","unstructured":"Zhu L, Li P, Gao D, Liu J, Liu Y, Sun C, et al. pH-sensitive loaded retinal\/indocyanine green micelles as an all-in-one theranostic agent for multi-modal imaging in vivo guided cellular senescence-photothermal synergistic therapy. Chem Commun. 2019;55:6209\u201312.","journal-title":"Chem Commun"},{"key":"2410_CR107","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.1002\/smll.201503961","volume":"12","author":"L Luo","year":"2016","unstructured":"Luo L, Bian Y, Liu Y, Zhang X, Wang M, Xing S, et al. Combined near infrared photothermal therapy and chemotherapy using gold nanoshells coated liposomes to enhance antitumor effect. Small. 2016;12:4103\u201312.","journal-title":"Small"},{"key":"2410_CR108","doi-asserted-by":"publisher","first-page":"109400","DOI":"10.1016\/j.eurpolymj.2019.109400","volume":"122","author":"IL Lu","year":"2020","unstructured":"Lu IL, Liu TI, Lin HC, Chang SH, Lo CL, Chiang WH, et al. IR780-loaded zwitterionic polymeric nanoparticles with acidity-induced agglomeration for enhanced tumor retention. Eur Polym J. 2020;122:109400.","journal-title":"Eur Polym J"},{"key":"2410_CR109","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1021\/acsbiomaterials.8b00379","volume":"4","author":"L Yu","year":"2018","unstructured":"Yu L, Dong A, Guo R, Yang M, Deng L, Zhang J. DOX\/ICG coencapsulated Liposome-Coated thermosensitive nanogels for NIR-Triggered simultaneous drug release and photothermal effect. ACS Biomater Sci Eng. 2018;4:2424\u201334.","journal-title":"ACS Biomater Sci Eng"},{"key":"2410_CR110","doi-asserted-by":"publisher","first-page":"5683","DOI":"10.1021\/acsami.6b16801","volume":"9","author":"HJ Yoon","year":"2017","unstructured":"Yoon HJ, Lee HS, Lim JY, Park JH. Liposomal indocyanine green for enhanced photothermal therapy. ACS Appl Mater Interfaces. 2017;9:5683\u201391.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2410_CR111","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jcis.2019.11.109","volume":"561","author":"SC Liao","year":"2020","unstructured":"Liao SC, Ting CW, Chiang WH. Functionalized polymeric nanogels with pH-sensitive benzoic-imine cross-linkages designed as vehicles for indocyanine green delivery. J Colloid Interface Sci. 2020;561:11\u201322.","journal-title":"J Colloid Interface Sci"},{"key":"2410_CR112","doi-asserted-by":"publisher","first-page":"430","DOI":"10.7150\/ntno.19935","volume":"1","author":"R Liu","year":"2017","unstructured":"Liu R, Tang J, Xu Y, Zhou Y, Dai Z. Nano-sized indocyanine green J-aggregate as a One-component theranostic agent. Nanotheranostics. 2017;1:430.","journal-title":"Nanotheranostics"},{"key":"2410_CR113","doi-asserted-by":"publisher","first-page":"112048","DOI":"10.1016\/j.colsurfb.2021.112048","volume":"208","author":"CW Ting","year":"2021","unstructured":"Ting CW, Chou YH, Huang SY, Chiang WH. Indocyanine green-carrying polymeric nanoparticles with acid-triggered detachable PEG coating and drug release for boosting cancer photothermal therapy. Colloids Surf B Biointerfaces. 2021;208:112048.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"2410_CR114","unstructured":"Trapoxin. an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase - PubMed."},{"key":"2410_CR115","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/bies.950170510","volume":"17","author":"M Yoshida","year":"1995","unstructured":"Yoshida M, Horinouchi S, Beppu T. Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function. BioEssays. 1995;17:423\u201330.","journal-title":"BioEssays"},{"key":"2410_CR116","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0163-7258(85)90083-X","volume":"28","author":"ID Goldman","year":"1985","unstructured":"Goldman ID, Matherly LH. The cellular Pharmacology of methotrexate. Pharmacol Ther. 1985;28:77\u2013102.","journal-title":"Pharmacol Ther"},{"key":"2410_CR117","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s00280-012-2062-0","volume":"71","author":"SS Abolmaali","year":"2013","unstructured":"Abolmaali SS, Tamaddon AM, Dinarvand R. A review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritis. Cancer Chemother Pharmacol. 2013;71:1115\u201330.","journal-title":"Cancer Chemother Pharmacol"},{"key":"2410_CR118","doi-asserted-by":"publisher","first-page":"102294","DOI":"10.1016\/j.jddst.2020.102294","volume":"61","author":"E Akbari","year":"2021","unstructured":"Akbari E, Mousazadeh H, Sabet Z, Fattahi T, Dehnad A, Akbarzadeh A, et al. Dual drug delivery of Trapoxin A and methotrexate from biocompatible PLGA-PEG polymeric nanoparticles enhanced antitumor activity in breast cancer cell line. J Drug Deliv Sci Technol. 2021;61:102294.","journal-title":"J Drug Deliv Sci Technol"},{"key":"2410_CR119","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0960-0760(01)00090-5","volume":"78","author":"RW Brueggemeier","year":"2001","unstructured":"Brueggemeier RW, Bhat AS, Lovely CJ, Coughenour HD, Joomprabutra S, Weitzel DH, et al. 2-Methoxymethylestradiol: a new 2-methoxy Estrogen analog that exhibits antiproliferative activity and alters tubulin dynamics. J Steroid Biochem Mol Biol. 2001;78:145\u201356.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2410_CR120","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1021\/mp100190f","volume":"7","author":"S Verenich","year":"2010","unstructured":"Verenich S, Gerk PM. Therapeutic promises of 2-Methoxyestradiol and its drug disposition challenges. Mol Pharm. 2010;7:2030.","journal-title":"Mol Pharm"},{"key":"2410_CR121","doi-asserted-by":"crossref","unstructured":"Nishiyama N, Kataoka K. Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol Ther [Internet]. 2006 [cited 2015 Sep 10];112:630\u201348. Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0163725806000933","DOI":"10.1016\/j.pharmthera.2006.05.006"},{"key":"2410_CR122","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3390\/polym3031377","volume":"3","author":"HK Makadia","year":"2011","unstructured":"Makadia HK, Siegel SJ. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polym (Basel). 2011;3:1377\u201397.","journal-title":"Polym (Basel)"},{"key":"2410_CR123","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.addr.2012.09.033","volume":"64","author":"L Brannon-Peppas","year":"2012","unstructured":"Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev. 2012;64:206\u201312.","journal-title":"Adv Drug Deliv Rev"},{"key":"2410_CR124","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.colsurfb.2016.11.040","volume":"150","author":"GJ Pillai","year":"2017","unstructured":"Pillai GJ, Paul-Prasanth B, Nair SV, Menon D. Influence of surface passivation of 2-Methoxyestradiol loaded PLGA nanoparticles on cellular interactions, pharmacokinetics and tumour accumulation. Colloids Surf B Biointerfaces. 2017;150:242\u20139.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"2410_CR125","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1517\/14728222.10.1.87","volume":"10","author":"BB Aggarwal","year":"2006","unstructured":"Aggarwal BB, Ichikawa H, Garodia P, Weerasinghe P, Sethi G, Bhatt ID, et al. From traditional ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer. Expert Opin Ther Targets. 2006;10:87\u2013118.","journal-title":"Expert Opin Ther Targets"},{"key":"2410_CR126","unstructured":"Phase I. Clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions - PubMed."},{"key":"2410_CR127","unstructured":"Pharmacodynamic. and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer - PubMed."},{"key":"2410_CR128","doi-asserted-by":"publisher","first-page":"6847","DOI":"10.1158\/1078-0432.CCR-04-0744","volume":"10","author":"RA Sharma","year":"2004","unstructured":"Sharma RA, Euden SA, Platton SL, Cooke DN, Shafayat A, Hewitt HR, et al. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res. 2004;10:6847\u201354.","journal-title":"Clin Cancer Res"},{"key":"2410_CR129","doi-asserted-by":"publisher","first-page":"16365","DOI":"10.1039\/C7NR06898K","volume":"9","author":"H Jin","year":"2017","unstructured":"Jin H, Pi J, Zhao Y, Jiang J, Li T, Zeng X, et al. EGFR-targeting PLGA-PEG nanoparticles as a Curcumin delivery system for breast cancer therapy. Nanoscale. 2017;9:16365\u201374.","journal-title":"Nanoscale"},{"key":"2410_CR130","unstructured":"Targeting. of piperine intercalated in mannose-coated liposomes in experimental leishmaniasis - PubMed."},{"key":"2410_CR131","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1007\/s00436-012-3054-z","volume":"111","author":"A Kumar","year":"2012","unstructured":"Kumar A, Raman RP, Kumar K, Pandey PK, Kumar V, Mohanty S, et al. Antiparasitic efficacy of Piperine against Argulus spp. On Carassius auratus (Linn. 1758): in vitro and in vivo study. Parasitol Res. 2012;111:2071\u20136.","journal-title":"Parasitol Res"},{"key":"2410_CR132","doi-asserted-by":"publisher","first-page":"102915","DOI":"10.1016\/j.pdpdt.2022.102915","volume":"39","author":"VR Shinde","year":"2022","unstructured":"Shinde VR, Revi N, Murugappan S, Singh SP, Rengan AK. Enhanced permeability and retention effect: A key facilitator for solid tumor targeting by nanoparticles. Photodiagnosis Photodyn Ther. 2022;39:102915.","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"2410_CR133","doi-asserted-by":"crossref","unstructured":"Pachauri M, Gupta ED, Ghosh PC. Piperine loaded PEG-PLGA nanoparticles: Preparation, characterization and targeted delivery for adjuvant breast cancer chemotherapy. J. Drug Deliv. Sci. Technol. Elsevier Ltd; 2015.","DOI":"10.1016\/j.jddst.2015.08.009"},{"key":"2410_CR134","doi-asserted-by":"publisher","first-page":"114271","DOI":"10.1016\/j.matdes.2025.114271","volume":"256","author":"M Li","year":"2025","unstructured":"Li M, Wan X, Shan B, He Y, Chen C, Shen M. A pH and GSH dual responsive nanoparticle co-deliver adriamycin and Olaparib enhanced the therapeutic efficacy on triple negative breast cancer. Mater Des. 2025;256:114271.","journal-title":"Mater Des"},{"key":"2410_CR135","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","volume":"307","author":"DE Owens","year":"2006","unstructured":"Owens DE, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm. 2006;307:93\u2013102.","journal-title":"Int J Pharm"},{"key":"2410_CR136","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.progpolymsci.2011.10.001","volume":"37","author":"L Casettari","year":"2012","unstructured":"Casettari L, Vllasaliu D, Castagnino E, Stolnik S, Howdle S, Illum L. PEGylated Chitosan derivatives: synthesis, characterizations and pharmaceutical applications. Prog Polym Sci. 2012;37:659\u201385.","journal-title":"Prog Polym Sci"},{"key":"2410_CR137","doi-asserted-by":"crossref","unstructured":"Khalil NM, Nascimento TCF do, Casa DM, Dalmolin LF, de Mattos AC, Hoss I et al. Pharmacokinetics of curcumin-loaded PLGA and PLGA-PEG blend nanoparticles after oral administration in rats. Colloids Surfaces B Biointerfaces. 2013;101:353\u201360.","DOI":"10.1016\/j.colsurfb.2012.06.024"},{"key":"2410_CR138","doi-asserted-by":"publisher","first-page":"101722","DOI":"10.1016\/j.jddst.2020.101722","volume":"57","author":"RS Prabhuraj","year":"2020","unstructured":"Prabhuraj RS, Bomb K, Srivastava R, Bandyopadhyaya R. Selection of superior targeting ligands using pegylated PLGA nanoparticles for delivery of Curcumin in the treatment of triple-negative breast cancer cells. J Drug Deliv Sci Technol. 2020;57:101722.","journal-title":"J Drug Deliv Sci Technol"},{"key":"2410_CR139","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.fitote.2010.11.016","volume":"82","author":"H Wagner","year":"2011","unstructured":"Wagner H. Synergy research: approaching a new generation of phytopharmaceuticals. Fitoterapia. 2011;82:34\u20137.","journal-title":"Fitoterapia"},{"key":"2410_CR140","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1080\/01635581.2017.1367932","volume":"69","author":"J Lotfi-Attari","year":"2017","unstructured":"Lotfi-Attari J, Pilehvar-Soltanahmadi Y, Dadashpour M, Alipour S, Farajzadeh R, Javidfar S, et al. Co-Delivery of Curcumin and Chrysin by polymeric nanoparticles inhibit synergistically growth and hTERT gene expression in human colorectal Cancer cells. Nutr Cancer. 2017;69:1290\u20139.","journal-title":"Nutr Cancer"},{"key":"2410_CR141","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1055\/s-0037-1600990","volume":"68","author":"R Bagheri","year":"2018","unstructured":"Bagheri R, Sanaat Z, Zarghami N. Synergistic effect of free and Nano-encapsulated Chrysin-Curcumin on Inhibition of hTERT gene expression in SW480 colorectal Cancer cell line. Drug Res (Stuttg). 2018;68:335\u201343.","journal-title":"Drug Res (Stuttg)"},{"key":"2410_CR142","doi-asserted-by":"publisher","first-page":"4063","DOI":"10.31557\/APJCP.2022.23.12.4063","volume":"23","author":"S Mohammadinejad","year":"2022","unstructured":"Mohammadinejad S, Jafari-Gharabaghlou D, Zarghami N. Development of pegylated PLGA nanoparticles Co-Loaded with bioactive compounds: potential anticancer effect on breast Cancer cell lines. Asian Pac J Cancer Prev. 2022;23:4063\u201372.","journal-title":"Asian Pac J Cancer Prev"},{"key":"2410_CR143","first-page":"1167","volume":"21","author":"D Jafari-Gharabaghlou","year":"2018","unstructured":"Jafari-Gharabaghlou D, Pilehvar-Soltanahmadi Y, Dadashpour M, Mota A, Vafajouy-Jamshidi S, Faramarzi L, et al. Combination of Metformin and phenformin synergistically inhibits proliferation and hTERT expression in human breast cancer cells. Iran J Basic Med Sci. 2018;21:1167\u201373.","journal-title":"Iran J Basic Med Sci"},{"key":"2410_CR144","first-page":"1283","volume":"18","author":"ZJ Maasomi","year":"2017","unstructured":"Maasomi ZJ, Soltanahmadi YP, Dadashpour M, Alipour S, Abolhasani S, Zarghami N. Synergistic anticancer effects of Silibinin and Chrysin in T47D breast Cancer cells. Asian Pac J Cancer Prev. 2017;18:1283.","journal-title":"Asian Pac J Cancer Prev"},{"key":"2410_CR145","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1039\/C7BM01206C","volume":"6","author":"Y Peng","year":"2018","unstructured":"Peng Y, Nie J, Cheng W, Liu G, Zhu D, Zhang L, et al. A multifunctional nanoplatform for cancer chemo-photothermal synergistic therapy and overcoming multidrug resistance. Biomater Sci. 2018;6:1084\u201398.","journal-title":"Biomater Sci"},{"key":"2410_CR146","doi-asserted-by":"crossref","unstructured":"Liou WS, Chen LJ, Niu HS, Yang TT, Cheng JT, Lin KC. Herbal product silibinin-induced programmed cell death is enhanced by Metformin in cervical cancer cells at the dose without influence on nonmalignant cells. http:\/\/jab.zsf.jcu.cz\/doi\/101016\/j.jab201411001.html. 2015;13:113\u201321.","DOI":"10.1016\/j.jab.2014.11.001"},{"key":"2410_CR147","doi-asserted-by":"publisher","first-page":"102107","DOI":"10.1016\/j.jddst.2020.102107","volume":"61","author":"S Amirsaadat","year":"2021","unstructured":"Amirsaadat S, Jafari-Gharabaghlou D, Alijani S, Mousazadeh H, Dadashpour M, Zarghami N. Metformin and Silibinin co-loaded PLGA-PEG nanoparticles for effective combination therapy against human breast cancer cells. J Drug Deliv Sci Technol. 2021;61:102107.","journal-title":"J Drug Deliv Sci Technol"},{"key":"2410_CR148","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejmech.2013.04.016","volume":"64","author":"Q Liu","year":"2013","unstructured":"Liu Q, Liu H, Zhang L, Guo T, Wang P, Geng M, et al. Synthesis and antitumor activities of naturally occurring oleanolic acid triterpenoid saponins and their derivatives. Eur J Med Chem. 2013;64:1\u201315.","journal-title":"Eur J Med Chem"},{"key":"2410_CR149","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jep.2005.05.024","volume":"100","author":"J Liu","year":"2005","unstructured":"Liu J. Oleanolic acid and ursolic acid: research perspectives. J Ethnopharmacol. 2005;100:92\u20134.","journal-title":"J Ethnopharmacol"},{"key":"2410_CR150","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11010-014-2228-7","volume":"400","author":"X Zhao","year":"2015","unstructured":"Zhao X, Liu M, Li D. Oleanolic acid suppresses the proliferation of lung carcinoma cells by miR-122\/Cyclin G1\/MEF2D axis. Mol Cell Biochem. 2015;400:1\u20137.","journal-title":"Mol Cell Biochem"},{"key":"2410_CR151","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1093\/carcin\/bgt058","volume":"34","author":"X Wang","year":"2013","unstructured":"Wang X, Bai H, Zhang X, Liu J, Cao P, Liao N, et al. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis. Carcinogenesis. 2013;34:1323\u201330.","journal-title":"Carcinogenesis"},{"key":"2410_CR152","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1021\/acs.molpharmaceut.5b00085","volume":"12","author":"DKW Man","year":"2015","unstructured":"Man DKW, Casettari L, Cespi M, Bonacucina G, Palmieri GF, Sze SCW, et al. Oleanolic acid loaded pegylated PLA and PLGA nanoparticles with enhanced cytotoxic activity against cancer cells. Mol Pharm. 2015;12:2112\u201325.","journal-title":"Mol Pharm"},{"key":"2410_CR153","doi-asserted-by":"publisher","first-page":"106436","DOI":"10.1016\/j.jddst.2024.106436","volume":"103","author":"DTT Le","year":"2025","unstructured":"Le DTT, Nguyen NH, Do HTM, Vu CM, Nguyen PTM, Chu HH. Honokiol-loaded PLGA-PEG nanoparticles with solubility in water for infusion treatment of solid cancer. J Drug Deliv Sci Technol. 2025;103:106436.","journal-title":"J Drug Deliv Sci Technol"},{"key":"2410_CR154","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/S0140-6736(11)60780-0","volume":"378","author":"E Quoix","year":"2011","unstructured":"Quoix E, Zalcman G, Oster JP, Westeel V, Pichon E, Lavol\u00e9 A, et al. Carboplatin and weekly Paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial. Lancet (London England). 2011;378:1079\u201388.","journal-title":"Lancet (London England)"},{"key":"2410_CR155","doi-asserted-by":"crossref","unstructured":"Morton SW, Lee MJ, Deng ZJ, Dreaden EC, Siouve E, Shopsowitz KE et al. A Nanoparticle-Based combination chemotherapy delivery system for enhanced tumor killing by dynamic rewiring of signaling pathways. 2014;7:1\u201311.","DOI":"10.1126\/scisignal.2005261"},{"key":"2410_CR156","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.bcp.2012.01.008","volume":"83","author":"CMJ Hu","year":"2012","unstructured":"Hu CMJ, Zhang L. Nanoparticle-based combination therapy toward overcoming drug resistance in cancer. Biochem Pharmacol. 2012;83:1104\u201311.","journal-title":"Biochem Pharmacol"},{"key":"2410_CR157","doi-asserted-by":"publisher","first-page":"7809","DOI":"10.1007\/s13277-015-4634-1","volume":"37","author":"Z He","year":"2016","unstructured":"He Z, Shi Z, Sun W, Ma J, Xia J, Zhang X, et al. Hemocompatibility of folic-acid-conjugated amphiphilic PEG-PLGA copolymer nanoparticles for co-delivery of cisplatin and paclitaxel: treatment effects for non-small-cell lung cancer. Tumor Biol. 2016;37:7809\u201321.","journal-title":"Tumor Biol"},{"key":"2410_CR158","doi-asserted-by":"publisher","first-page":"9217","DOI":"10.1021\/acsnano.5b03876","volume":"9","author":"Q Xu","year":"2015","unstructured":"Xu Q, Ensign LM, Boylan NJ, Sch\u00f6n A, Gong X, Yang JC, et al. Impact of surface polyethylene glycol (PEG) density on biodegradable nanoparticle transport in mucus ex vivo and distribution in vivo. ACS Nano. 2015;9:9217\u201327.","journal-title":"ACS Nano"},{"key":"2410_CR159","doi-asserted-by":"publisher","first-page":"8720","DOI":"10.1073\/pnas.1502281112","volume":"112","author":"P Mastorakos","year":"2015","unstructured":"Mastorakos P, Silva ALD, Chisholm J, Song E, Choi WK, Boyle MP, et al. Highly compacted biodegradable DNA nanoparticles capable of overcoming the mucus barrier for inhaled lung gene therapy. Proc Natl Acad Sci U S A. 2015;112:8720\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2410_CR160","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jconrel.2018.03.011","volume":"277","author":"C Conte","year":"2018","unstructured":"Conte C, Mastrotto F, Taresco V, Tchoryk A, Quaglia F, Stolnik S, et al. Enhanced uptake in 2D- and 3D- lung cancer cell models of redox responsive pegylated nanoparticles with sensitivity to reducing extra- and intracellular environments. J Control Release. 2018;277:126\u201341.","journal-title":"J Control Release"},{"key":"2410_CR161","doi-asserted-by":"crossref","unstructured":"Zhao Qsheng, Hu L, ling, Wang Z dong, Li Z, pei, Wang A, wen, Liu J. Resveratrol-loaded folic acid-grafted dextran stearate submicron particles exhibits enhanced antitumor efficacy in non-small cell lung cancers. Mater Sci Eng C Mater Biol Appl. 2017;72:185\u201391.","DOI":"10.1016\/j.msec.2016.10.077"},{"key":"2410_CR162","doi-asserted-by":"publisher","first-page":"288","DOI":"10.21037\/tlcr.2016.06.07","volume":"5","author":"C Zappa","year":"2016","unstructured":"Zappa C, Mousa SA. Non-small cell lung cancer: current treatment and future advances. Transl Lung Cancer Res. 2016;5:288.","journal-title":"Transl Lung Cancer Res"},{"key":"2410_CR163","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1093\/jnci\/djq279","volume":"102","author":"AF Gazdar","year":"2010","unstructured":"Gazdar AF, Girard L, Lockwood WW, Lam WL, Minna JD. Lung cancer cell lines as tools for biomedical discovery and research. J Natl Cancer Inst. 2010;102:1310\u201321.","journal-title":"J Natl Cancer Inst"},{"key":"2410_CR164","doi-asserted-by":"crossref","unstructured":"Asif U, Sherwani AK, Akhtar N, Shoaib MH, Hanif M, Qadir MI et al. Formulation development and optimization of febuxostat tablets by direct compression method. Adv Polym Technol. 2016;35.","DOI":"10.1002\/adv.21536"},{"key":"2410_CR165","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13205-020-2077-x","volume":"10","author":"MY Alfaifi","year":"2020","unstructured":"Alfaifi MY, Shati AA, Eldin S, Fahmy UA, Alhakamy NA. Anti\u2013 tumor effect of PEG\u2013 coated PLGA nanoparticles of febuxostat on A549 non\u2013 small cell lung cancer cells. 3 Biotech. 2020;10:1\u201310.","journal-title":"3 Biotech"},{"key":"2410_CR166","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1146\/annurev.pathol.1.110304.100103","volume":"1","author":"II Wistuba","year":"2006","unstructured":"Wistuba II, Gazdar AF. Lung cancer preneoplasia. Annu Rev Pathol Mech Dis. 2006;1:331\u201348.","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"2410_CR167","doi-asserted-by":"crossref","unstructured":"Mostofa AGM, Hossain MK, Basak D, Sayeed MS, Bin. Thymoquinone as a potential adjuvant therapy for Cancer treatment: evidence from preclinical studies. Front Pharmacol. 2017;8.","DOI":"10.3389\/fphar.2017.00295"},{"key":"2410_CR168","unstructured":"Manuscript A. Biomaterials Science. 2019."},{"key":"2410_CR169","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nrd4010","volume":"12","author":"LP Jordheim","year":"2013","unstructured":"Jordheim LP, Durantel D, Zoulim F, Dumontet C. Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases. Nat Rev Drug Discov. 2013;12:447\u201364.","journal-title":"Nat Rev Drug Discov"},{"key":"2410_CR170","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ijpharm.2014.05.005","volume":"470","author":"V Khare","year":"2014","unstructured":"Khare V, Kour S, Alam N, Dubey RD, Saneja A, Koul M, et al. Synthesis, characterization and mechanistic-insight into the anti-proliferative potential of PLGA-gemcitabine conjugate. Int J Pharm. 2014;470:51\u201362.","journal-title":"Int J Pharm"},{"key":"2410_CR171","doi-asserted-by":"publisher","first-page":"61948","DOI":"10.1039\/C4RA10431E","volume":"4","author":"M Tan","year":"2014","unstructured":"Tan M, Luo J, Tian Y. Delivering Curcumin and gemcitabine in one nanoparticle platform for colon cancer therapy. RSC Adv. 2014;4:61948\u201359.","journal-title":"RSC Adv"},{"key":"2410_CR172","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/nm1095-1046","volume":"1","author":"E Pisha","year":"1995","unstructured":"Pisha E, Chai H, Lee IS, Chagwedera TE, Farnsworth NR, Cordell GA, et al. Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat Med. 1995;1:1046\u201351.","journal-title":"Nat Med"},{"key":"2410_CR173","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.msec.2016.12.109","volume":"73","author":"A Saneja","year":"2017","unstructured":"Saneja A, Sharma L, Dubey RD, Mintoo MJ, Singh A, Kumar A, et al. Synthesis, characterization and augmented anticancer potential of PEG-betulinic acid conjugate. Mater Sci Eng C Mater Biol Appl. 2017;73:616\u201326.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"2410_CR174","doi-asserted-by":"crossref","unstructured":"Saneja A, Kumar R, Mintoo MJ, Dubey RD, Sangwan PL, Mondhe DM et al. Gemcitabine and betulinic acid co-encapsulated PLGA-PEG polymer nanoparticles for improved efficacy of cancer chemotherapy. Mater Sci Eng C [Internet]. 2019;98:764\u201371. Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S092849311832589X","DOI":"10.1016\/j.msec.2019.01.026"},{"key":"2410_CR175","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.3892\/or.2016.5067","volume":"36","author":"PJ Pak","year":"2016","unstructured":"Pak PJ, Kang BH, Park SH, Sung JH, Joo YH, Jung SH, et al. Antitumor effects of herbal mixture extract in the pancreatic adenocarcinoma cell line PANC1. Oncol Rep. 2016;36:2875\u201383.","journal-title":"Oncol Rep"},{"key":"2410_CR176","first-page":"9384","volume":"20","author":"M Kanai","year":"2014","unstructured":"Kanai M. Therapeutic applications of Curcumin for patients with pancreatic cancer. World J Gastroenterol. 2014;20:9384.","journal-title":"World J Gastroenterol"},{"key":"2410_CR177","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1158\/1535-7163.MCT-10-0172","volume":"9","author":"S Bisht","year":"2010","unstructured":"Bisht S, Mizuma M, Feldmann G, Ottenhof NA, Hong S-M, Pramanik D, et al. Systemic administration of polymeric nanoparticle-encapsulated Curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer. Mol Cancer Ther. 2010;9:2255\u201364.","journal-title":"Mol Cancer Ther"},{"key":"2410_CR178","doi-asserted-by":"crossref","unstructured":"Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm 2007. pp. 807\u201318.","DOI":"10.1021\/mp700113r"},{"key":"2410_CR179","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.reactfunctpolym.2016.12.011","volume":"C","author":"R Feng","year":"2017","unstructured":"Feng R, Deng P, Song Z, Chu W, Zhu W, Teng F, et al. Glycyrrhetinic acid-modified PEG-PCL copolymeric micelles for the delivery of Curcumin. React Funct Polym. 2017;C:30\u20137.","journal-title":"React Funct Polym"},{"key":"2410_CR180","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.biopha.2017.01.033","volume":"88","author":"F Teng","year":"2017","unstructured":"Teng F, Deng P, Song Z, Zhou F, Feng R. Enhanced effect in combination of curcumin- and ketoconazole-loaded methoxy Poly (ethylene glycol)-poly (\u03b5-caprolactone) micelles. Biomed Pharmacother. 2017;88:43\u201351.","journal-title":"Biomed Pharmacother"},{"key":"2410_CR181","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.biopha.2018.03.101","volume":"102","author":"G Arya","year":"2018","unstructured":"Arya G, Das M, Sahoo SK. Biomedicine & pharmacotherapy evaluation of Curcumin loaded chitosan \/ PEG blended PLGA nanoparticles for e Ff ective treatment of pancreatic cancer. Biomed Pharmacother. 2018;102:555\u201366.","journal-title":"Biomed Pharmacother"},{"key":"2410_CR182","doi-asserted-by":"crossref","unstructured":"Fu Y, Tan L, Meng L, Lei X. Therapeutic effects of Paclitaxel loaded polyethylene nanoparticles on pancreatic Cancer in rats. 2020;20:7271\u20135.","DOI":"10.1166\/jnn.2020.18608"},{"key":"2410_CR183","doi-asserted-by":"publisher","first-page":"107073","DOI":"10.1016\/j.jddst.2025.107073","volume":"110","author":"Z Liang","year":"2025","unstructured":"Liang Z, Li J, Huang H, Jiang H, Luo L, Li S, et al. Glucose-modified PEG-PLA self-assembled nano-micelles optimize DOX enrichment, tissue penetration, and tumor suppression effects in pancreatic ductal adenocarcinoma. J Drug Deliv Sci Technol. 2025;110:107073.","journal-title":"J Drug Deliv Sci Technol"},{"key":"2410_CR184","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.jnutbio.2014.11.017","volume":"26","author":"P Wang","year":"2015","unstructured":"Wang P, Henning SM, Heber D, Vadgama JV. Sensitization to docetaxel in prostate cancer cells by green tea and Quercetin. J Nutr Biochem. 2015;26:408\u201315.","journal-title":"J Nutr Biochem"},{"key":"2410_CR185","doi-asserted-by":"publisher","first-page":"27542","DOI":"10.1039\/C6RA00460A","volume":"6","author":"C Xu","year":"2016","unstructured":"Xu C, Ding Y, Ni J, Yin L, Zhou J, Yao J. Tumor-targeted docetaxel-loaded hyaluronic acid-quercetin polymeric micelles with p-gp inhibitory property for hepatic cancer therapy. RSC Adv. 2016;6:27542\u201356.","journal-title":"RSC Adv"},{"key":"2410_CR186","first-page":"1","volume":"61","author":"S Zhu","year":"2016","unstructured":"Zhu S, Wang Q, Jiang J, Luo Y, Sun Z. A conjugate of methotrexate and an analog of luteinizing hormone releasing hormone shows increased efficacy against prostate cancer. Sci Rep 2016. 2016;61:6:1\u20139.","journal-title":"Sci Rep 2016"},{"key":"2410_CR187","doi-asserted-by":"crossref","unstructured":"Shitole AA, Sharma N, Giram P, Khandwekar A, Baruah M, Garnaik B et al. LHRH-conjugated, pegylated, poly-lactide-co-glycolide nanocapsules for targeted delivery of combinational chemotherapeutic drugs docetaxel and Quercetin for prostate cancer. Mater Sci Eng C Mater Biol Appl. 2020;114.","DOI":"10.1016\/j.msec.2020.111035"},{"key":"2410_CR188","doi-asserted-by":"publisher","first-page":"103766","DOI":"10.1016\/j.xphs.2025.103766","volume":"114","author":"L Silva","year":"2025","unstructured":"Silva L, de QC, Raspantini GL, Abriata JP, Luiz MT, de Sousa ACC, da Moreira T. PLGA\/TPGS nanoparticles for docetaxel delivery: the pegylation effect on nanoparticle physicochemical properties and uptake and cytotoxicity in prostate cancer cells. J Pharm Sci. 2025;114:103766.","journal-title":"J Pharm Sci"},{"key":"2410_CR189","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.eururo.2014.10.023","volume":"67","author":"AW Glaser","year":"2015","unstructured":"Glaser AW, Corner JL. Prostate cancer outcomes: the three questions. Eur Urol. 2015;67:357\u20138.","journal-title":"Eur Urol"},{"key":"2410_CR190","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.rpor.2013.10.006","volume":"18","author":"WR Polkinghorn","year":"2013","unstructured":"Polkinghorn WR, Zelefsky MJ. Improving outcomes in high-risk prostate cancer with radiotherapy. Rep Pract Oncol Radiother. 2013;18:333.","journal-title":"Rep Pract Oncol Radiother"},{"key":"2410_CR191","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.meddos.2013.12.006","volume":"39","author":"A Carosi","year":"2014","unstructured":"Carosi A, Ingrosso G, Ponti E, Tolu B, Murgia A, Di Cristino D, et al. Dosimetric effect of Elekta beam modulator micromultileaf in three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer. Med Dosim. 2014;39:180\u20134.","journal-title":"Med Dosim"},{"key":"2410_CR192","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.actbio.2020.09.029","volume":"117","author":"D Dinakaran","year":"2020","unstructured":"Dinakaran D, Sengupta J, Pink D, Raturi A, Chen H, Usmani N, et al. PEG-PLGA nanospheres loaded with nanoscintillators and photosensitizers for radiation-activated photodynamic therapy. Acta Biomater. 2020;117:335\u201348.","journal-title":"Acta Biomater"},{"key":"2410_CR193","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jcis.2010.05.022","volume":"351","author":"MM Yallapu","year":"2010","unstructured":"Yallapu MM, Gupta BK, Jaggi M, Chauhan SC. Fabrication of Curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. J Colloid Interface Sci. 2010;351:19\u201329.","journal-title":"J Colloid Interface Sci"},{"key":"2410_CR194","first-page":"1083","volume":"9","author":"L Li","year":"2014","unstructured":"Li L, Xiang D, Shigdar S, Yang W, Li Q, Lin J, et al. Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells. Int J Nanomed. 2014;9:1083\u201396.","journal-title":"Int J Nanomed"},{"key":"2410_CR195","doi-asserted-by":"publisher","first-page":"4704","DOI":"10.1002\/smll.201403799","volume":"11","author":"R Klippstein","year":"2015","unstructured":"Klippstein R, Wang JTW, El-Gogary RI, Bai J, Mustafa F, Rubio N, et al. Passively targeted Curcumin-Loaded pegylated PLGA nanocapsules for Colon cancer therapy in vivo. Small. 2015;11:4704\u201322.","journal-title":"Small"},{"key":"2410_CR196","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrc1074","volume":"3","author":"DB Longley","year":"2003","unstructured":"Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003;3:330\u20138.","journal-title":"Nat Rev Cancer"},{"key":"2410_CR197","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ijpharm.2016.11.012","volume":"516","author":"MM El-Hammadi","year":"2017","unstructured":"El-Hammadi MM, Delgado \u00c1V, Melguizo C, Prados JC, Arias JL. Folic acid-decorated and pegylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil. Int J Pharm. 2017;516:61\u201370.","journal-title":"Int J Pharm"},{"key":"2410_CR198","doi-asserted-by":"crossref","unstructured":"Kuipers EJ, Grady WM, Lieberman D, Seufferlein T, Sung JJ, Boelens PG et al. Colorectal cancer. Nat Rev Dis Prim. 2015;1.","DOI":"10.1038\/nrdp.2015.65"},{"key":"2410_CR199","first-page":"233","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73:233\u201354.","journal-title":"CA Cancer J Clin"},{"key":"2410_CR200","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jconrel.2024.01.041","volume":"367","author":"J Peng","year":"2024","unstructured":"Peng J, Zhou J, Liu X, Zhang X, Zhou X, Gong Z, et al. A biomimetic nanocarrier facilitates glucose consumption and reactive oxide species accumulation in enzyme therapy for colorectal cancer. J Control Release. 2024;367:76\u201392.","journal-title":"J Control Release"},{"key":"2410_CR201","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/nrc1123","volume":"3","author":"R Agarwal","year":"2003","unstructured":"Agarwal R, Kaye SB. Ovarian cancer: strategies for overcoming resistance to chemotherapy. Nat Rev Cancer. 2003;3:502\u201316.","journal-title":"Nat Rev Cancer"},{"key":"2410_CR202","unstructured":"VANGARA KK, LIU JL. PALAKURTHI S. Hyaluronic Acid-decorated PLGA-PEG nanoparticles for targeted delivery of SN-38 to ovarian Cancer. Anticancer Res. 2013;33."},{"key":"2410_CR203","doi-asserted-by":"crossref","unstructured":"A comprehensive anticancer. Molecular study for genistein the promising anticancer drug. J Contemp Med Sci. 2017;3.","DOI":"10.22317\/jcms.09201704"},{"key":"2410_CR204","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S2225-4110(16)30082-7","volume":"2","author":"JY Lee","year":"2012","unstructured":"Lee JY, Kim H, Song YS. Genistein as a potential anticancer agent against ovarian Cancer. J Tradit Complement Med. 2012;2:96.","journal-title":"J Tradit Complement Med"},{"key":"2410_CR205","doi-asserted-by":"crossref","unstructured":"Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez-Torres MDP, Acosta-Torres LS et al. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol. 2018;16.","DOI":"10.1186\/s12951-018-0392-8"},{"key":"2410_CR206","doi-asserted-by":"crossref","unstructured":"Lu Q, Gao W, Chen Z, Liu Z, Wang J, Zeng L et al. Co-delivery of Paclitaxel\/Atovaquone\/Quercetin to regulate energy metabolism to reverse multidrug resistance in ovarian cancer by PLGA-PEG nanoparticles. Int J Pharm [Internet]. 2024 [cited 2025 Jul 14];655:124028. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S037851732400262X#f0045","DOI":"10.1016\/j.ijpharm.2024.124028"},{"key":"2410_CR207","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s11095-006-9905-5","volume":"23","author":"JMR Parepally","year":"2006","unstructured":"Parepally JMR, Mandula H, Smith QR. Brain uptake of nonsteroidal anti-inflammatory drugs: ibuprofen, flurbiprofen, and indomethacin. Pharm Res. 2006;23:873\u201381.","journal-title":"Pharm Res"},{"key":"2410_CR208","doi-asserted-by":"publisher","first-page":"119076","DOI":"10.1016\/j.ijpharm.2020.119076","volume":"578","author":"S Caban-Toktas","year":"2020","unstructured":"Caban-Toktas S, Sahin A, Lule S, Esendagli G, Vural I, Karl\u0131 Oguz K, et al. Combination of Paclitaxel and R-flurbiprofen loaded PLGA nanoparticles suppresses glioblastoma growth on systemic administration. Int J Pharm. 2020;578:119076.","journal-title":"Int J Pharm"},{"key":"2410_CR209","doi-asserted-by":"crossref","unstructured":"Anjum K, Shagufta BI, Abbas SQ, Patel S, Khan I, Shah SAA, et al. Current status and future therapeutic perspectives of glioblastoma multiforme (GBM) therapy: A review. Biomed. Pharmacother. Elsevier Masson SAS; 2017. pp. 681\u20139.","DOI":"10.1016\/j.biopha.2017.05.125"},{"key":"2410_CR210","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jconrel.2020.01.009","volume":"320","author":"LL Israel","year":"2020","unstructured":"Israel LL, Galstyan A, Holler E, Ljubimova JY. Magnetic iron oxide nanoparticles for imaging, targeting and treatment of primary and metastatic tumors of the brain. J Control Release. 2020;320:45\u201362.","journal-title":"J Control Release"},{"key":"2410_CR211","doi-asserted-by":"publisher","first-page":"167970","DOI":"10.1016\/j.jmmm.2021.167970","volume":"533","author":"K Jani","year":"2021","unstructured":"Jani K, Kaushal N, Sadoqi M, Long G, Chen ZS, Squillante E. Formulation and characterization of oleic acid magnetic PEG PLGA nanoparticles for targeting glioblastoma multiforme. J Magn Magn Mater. 2021;533:167970.","journal-title":"J Magn Magn Mater"},{"key":"2410_CR212","doi-asserted-by":"publisher","first-page":"6615","DOI":"10.3390\/ijms24076615","volume":"24","author":"MD Fulton","year":"2023","unstructured":"Fulton MD, Najahi-Missaoui W. Liposomes in Cancer therapy: how did we start and where are we now. Int J Mol Sci. 2023;24:6615.","journal-title":"Int J Mol Sci"},{"key":"2410_CR213","doi-asserted-by":"crossref","unstructured":"Crintea A, Motofelea AC, \u0218ovrea AS, Constantin AM, Crivii CB, Carpa R et al. Dendrimers: Advancements and Potential Applications in Cancer Diagnosis and Treatment\u2014An Overview. Pharm 2023, Vol 15, Page 1406. 2023;15:1406.","DOI":"10.3390\/pharmaceutics15051406"},{"key":"2410_CR214","doi-asserted-by":"publisher","first-page":"103386","DOI":"10.1016\/j.drudis.2022.103386","volume":"27","author":"MJN Amaldoss","year":"2022","unstructured":"Amaldoss MJN, Yang JL, Koshy P, Unnikrishnan A, Sorrell CC. Inorganic nanoparticle-based advanced cancer therapies: promising combination strategies. Drug Discov Today. 2022;27:103386.","journal-title":"Drug Discov Today"},{"key":"2410_CR215","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3390\/pharmaceutics14030614","volume":"14","author":"YW Lim","year":"2022","unstructured":"Lim YW, Tan WS, Ho KL, Mariatulqabtiah AR, Kasim NHA, Abd. Rahman N, et al. Challenges and complications of Poly(lactic-co-glycolic acid)-Based Long-Acting drug product development. Pharmaceutics. 2022;14:614.","journal-title":"Pharmaceutics"},{"key":"2410_CR216","doi-asserted-by":"crossref","unstructured":"Jani K, Kaushal N. Clinical translation of PLGA nanoparticles into market\u2014From benchside to breakthrough therapy. Poly(lactic-co-glycolic acid). Nanopart Drug Deliv. 2023;433\u201356.","DOI":"10.1016\/B978-0-323-91215-0.00013-3"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02410-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-025-02410-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02410-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T23:20:06Z","timestamp":1757287206000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-025-02410-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":216,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2410"],"URL":"https:\/\/doi.org\/10.1186\/s12943-025-02410-x","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,24]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"205"}}